Folinic Acid Calcium Salt Pentahydrate
CAS No. 6035-45-6
Folinic Acid Calcium Salt Pentahydrate ( —— )
Catalog No. M15258 CAS No. 6035-45-6
Folinic Acid is a reduced folic acid, which is used in combination with other chemotherapy drugs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 37 | In Stock |
|
| 500MG | 76 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFolinic Acid Calcium Salt Pentahydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionFolinic Acid is a reduced folic acid, which is used in combination with other chemotherapy drugs.
-
DescriptionFolinic Acid is a reduced folic acid, which is used in combination with other chemotherapy drugs.(In Vitro):MTX alone induces a concentration-related increase in % micronucleated binucleated cells (MNBN) and % aberrant cells (Abs). There is a decrease in nuclear division index (NDI) with increase in MTX concentration. Similarly, the mitotic index (MI) also decreases in all concentrations of MTX tested. The addition of Folinic acid at 50 μg/ mL significantly reduces % MNBN (40-68%) and % Abs (36-77%). Inhibition is also seen at 5 μg/ mL Folinic acid (12 to 54% for MNBN and 20 to 61% for Abs) .(In Vivo):Folinic acid (7.0 mg/kg; intraperitoneal injection; every second day; for 3 weeks; Balb/c young growing male mice) treatment following methotrexate (MTX) administration appears to reverse this growth inhibition (Chronic administration of MTX induces suppression of skeletal growth in mice).
-
In VitroMTX alone induces a concentration-related increase in % micronucleated binucleated cells (MNBN) and % aberrant cells (Abs). There is a decrease in nuclear division index (NDI) with increase in MTX concentration. Similarly, the mitotic index (MI) also decreases in all concentrations of MTX tested. The addition of Folinic acid at 50 μg/ mL significantly reduces % MNBN (40-68%) and % Abs (36-77%). Inhibition is also seen at 5 μg/ mL Folinic acid (12 to 54% for MNBN and 20 to 61% for Abs) .
-
In VivoFolinic acid (7.0 mg/kg; intraperitoneal injection; every second day; for 3 weeks; Balb/c young growing male mice) treatment following methotrexate (MTX) administration appears to reverse this growth inhibition (Chronic administration of MTX induces suppression of skeletal growth in mice). Animal Model:24 Balb/c young growing male mice aged 3 weeks (11.88 ± 0.25 g) Dosage:7.0 mg/kg Administration:Intraperitoneal injection; every second day; for 3 weeks Result:Following methotrexate (MTX) administration appears to reverse this growth inhibition.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorFolate Analogue
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number6035-45-6
-
Formula Weight601.58
-
Molecular FormulaC20H21CaN7O7·5H2O
-
Purity>98% (HPLC)
-
SolubilityWater: 40 mg/mL warmed (66.49 mM)
-
SMILESNC1=NC(=O)C2=C(NCC(CNC3=CC=C(C=C3)C(=O)NC(CCC(O)=O)C(O)=O)N2C=O)N1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Van der Wilt CL, et al. Y Res, 1992, 52(18), 4922-4928.
molnova catalog
related products
-
NSC756093
NSC756093 potentially inhibits GBP1:PIM1 interaction. NSC756093 can be used in ovarian cancer studies.
-
Mitoxantrone
Mitoxantrone is an anthracenedione antibiotic with antineoplastic activity. Mitoxantrone intercalates into and crosslinks DNA, thereby disrupting DNA and RNA replication.
-
Rhein-8-glucoside
Rhein-8-glucoside has low laxative activity.
Cart
sales@molnova.com